Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 13, 2025 08:30 ET | Source: Inquis Medical

Inquis Medical Completes Enrollment in U.S. Pivotal IDE Trial of the Aventus Thrombectomy System Designed to Treat Patients with Pulmonary Embolism

Inquis Medical Completes Enrollment in AVENTUS US Pivotal IDE Trial of the Aventus Thrombectomy System Designed to Treat Patients with Pulmonary Embolism
October 16, 2023 08:13 ET | Source: The Insight Partners

Coagulation Market Worth $10.85 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners

Pune, India, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Coagulation or clotting is the process by which blood turns from a liquid into a gel and forms a blood clot. This potentially leads to hemostasis,...
March 20, 2023 17:30 ET | Source: Transparency Market Research

Antiplatelet Drugs Market to Hit USD 4.1 Bn by 2031 Due to the Increase in Prevalence of Cardiovascular Diseases, Latest Study by TMR

Wilmington, Delaware, United States, March 21, 2023 (GLOBE NEWSWIRE) -- According to Transparency Market Research, the global antiplatelet drugs market size was valued USD 2.1 Bn in 2022 and it is...
December 07, 2022 11:00 ET | Source: Association of American Physicians and Surgeons (AAPS)

AAPS Executive Director in Journal of American Physicians and Surgeons Discusses Whether Blood Clots After COVID Vaccines Are an Ignored Crisis

TUCSON, Ariz., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Despite official reassurances that adverse effects of COVID vaccines are rare or mild, some patients still have concerns, and social media is filled...
February 11, 2022 06:26 ET | Source: The Insight Partners

Low Molecular Weight Heparin Market Size Worth $5,733.96 Mn, Globally, by 2028 at 6.6% CAGR - Exclusive Report by The Insight Partners

New York, Feb. 11, 2022 (GLOBE NEWSWIRE) -- The latest research study on “Low Molecular Weight Heparin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Enoxaparin,...
October 02, 2019 09:35 ET | Source: Stop the Clot, Spread the Word™

Blood Clot Risk among People with Cancer

GAITHERSBURG, Md., Oct. 02, 2019 (GLOBE NEWSWIRE) -- The National Blood Clot Alliance (NBCA) and the Centers for Disease Control and Prevention (CDC) are rolling out a new suite of resources from...
September 08, 2011 18:26 ET | Source: American Heart Association

AHA Perspective on FDA Committee Decision on Rivaroxaban

DALLAS, Sept. 8, 2011 (GLOBE NEWSWIRE) -- The American Heart Association notes the FDA advisory committee's recommendation today to give market approval for rivaroxaban, an oral anticoagulant drug,...